{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:49:38Z","timestamp":1770781778817,"version":"3.50.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan Inc.","doi-asserted-by":"crossref","award":["89045293"],"award-info":[{"award-number":["89045293"]}],"id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35878-8","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:15:12Z","timestamp":1768832112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variations in the perceived value of anti-SARS-CoV-2 therapeutics based on physicians\u2019 clinical backgrounds"],"prefix":"10.1038","volume":"16","author":[{"given":"Akihiko","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiki","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinyu","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Sakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"35878_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"YD Gao","year":"2021","unstructured":"Gao, Y. D. et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 76, 428\u2013455 (2021).","journal-title":"Allergy"},{"key":"35878_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12879-024-09131-4","volume":"24","author":"K Sakuramoto","year":"2024","unstructured":"Sakuramoto, K. et al. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and Omicron variants in tertiary hospitals of Japan. BMC Infect. Dis. 24, 223 (2024).","journal-title":"BMC Infect. Dis."},{"key":"35878_CR3","unstructured":"Infectious Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (2025). https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/"},{"key":"35878_CR4","unstructured":"The World Health Organization. Therapeutics and COVID-19: living guideline. (2025). ttps:\/\/app.magicapp.org\/#\/guideline\/7789\/section\/149650"},{"key":"35878_CR5","doi-asserted-by":"crossref","unstructured":"Komiya, K. et al. Influence of educational films on antiviral prescription for COVID-19: insights from web-based survey in Japan. Antibiotics 14, 276 (2025).","DOI":"10.3390\/antibiotics14030276"},{"key":"35878_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/14737167.2024.2410963","volume":"25","author":"M Nagano","year":"2025","unstructured":"Nagano, M., Hyokai, S., Togo, K., Mugwagwa, T. & Yuasa, A. Impact of patient\u2019s financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes. Expert Rev. Pharmacoecon Outcomes Res. 25, 215\u2013225 (2025).","journal-title":"Expert Rev. Pharmacoecon Outcomes Res."},{"key":"35878_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.36469\/jheor.2025.129067","volume":"12","author":"A Yuasa","year":"2025","unstructured":"Yuasa, A. et al. Cost-effectiveness analysis of Nirmatrelvir\/Ritonavir compared with molnupiravir in patients at high risk for progression to severe COVID-19 in Japan. J. Health Econ. Outcomes Res. 12, 75\u201385 (2025).","journal-title":"J. Health Econ. Outcomes Res."},{"key":"35878_CR8","unstructured":"Ministry of Health, Labour and Welfare. Various Information of Medical Fee (2025). https:\/\/shinryohoshu.mhlw.go.jp\/shinryohoshu\/searchMenu\/doSearchInputYp?utm_source=chatgpt.com"},{"key":"35878_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jiac.2022.12.003","volume":"29","author":"D Tomidokoro","year":"2023","unstructured":"Tomidokoro, D. et al. Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities. J. Infect. Chemother. 29, 302\u2013308 (2023).","journal-title":"J. Infect. Chemother."},{"key":"35878_CR10","unstructured":"Denig, P. Drug choice in medical practice: rationales, routines and remedies. Groningen: Univ. Groningen. 7\u201322 (1994)."},{"key":"35878_CR11","first-page":"795","volume":"28","author":"M Davari","year":"2018","unstructured":"Davari, M., Khorasani, E. & Tigabu, B. M. Factors influencing prescribing decisions of physicians: a review. Ethiop. J. Health Sci. 28, 795\u2013804 (2018).","journal-title":"Ethiop. J. Health Sci."},{"key":"35878_CR12","first-page":"62","volume":"2","author":"F Ya\u011far","year":"2017","unstructured":"Ya\u011far, F. & D\u00f6kme Ya\u011far, S. Evaluation of factors affecting drug choice of physicians. Int. J. Health Manage. Tourism. 2, 62\u201374 (2017).","journal-title":"Int. J. Health Manage. Tourism"},{"key":"35878_CR13","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1371\/journal.pmed.0040283","volume":"4","author":"GM Allan","year":"2007","unstructured":"Allan, G. M., Lexchin, J. & Wiebe, N. Physician awareness of drug cost: a systematic review. PLoS Med. 4, e283 (2007).","journal-title":"PLoS Med."},{"key":"35878_CR14","doi-asserted-by":"publisher","first-page":"e75218","DOI":"10.1371\/journal.pone.0075218","volume":"8","author":"II Eriksen","year":"2013","unstructured":"Eriksen, I. I., Melberg, H. O. & Bringedal, B. Norwegian physicians\u2019 knowledge of the prices of pharmaceuticals: a survey. PLoS One. 8, e75218 (2013).","journal-title":"PLoS One"},{"key":"35878_CR15","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1345\/aph.1H158","volume":"40","author":"WH Shrank","year":"2006","unstructured":"Shrank, W. H. et al. Physicians\u2019 perceived knowledge of and responsibility for managing patients\u2019 out-of-pocket costs for prescription drugs. Ann. Pharmacother. 40, 1534\u20131540 (2006).","journal-title":"Ann. Pharmacother"},{"key":"35878_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12889-023-17531-5","volume":"24","author":"S Koike","year":"2024","unstructured":"Koike, S. et al. Working hours of full-time hospital physicians in japan: a cross-sectional nationwide survey. BMC Public. Health. 24, 164 (2024).","journal-title":"BMC Public. Health"},{"key":"35878_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1472-6963-14-375","volume":"14","author":"M Nohara","year":"2014","unstructured":"Nohara, M., Yoshikawa, T., Nakajima, N. & Okutsu, K. Hospital physicians perform five types of work duties in japan: an observational study. BMC Health Serv. Res. 14, 375 (2014).","journal-title":"BMC Health Serv. Res."},{"key":"35878_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13063-023-07450-6","volume":"24","author":"D Kang","year":"2023","unstructured":"Kang, D., Huang, C. X., Yuen, A. D., Norris, K. C. & Vijayan, T. Do hospitals that participate in COVID-19 research differ from non-trial hospitals? A cross-sectional study of US hospitals. Trials 24, 504 (2023).","journal-title":"Trials"},{"key":"35878_CR19","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.clinthera.2015.07.024","volume":"37","author":"CL Chou","year":"2015","unstructured":"Chou, C. L. et al. Analysis of prescription pattern and guideline adherence in the management of asthma among medical institutions and physician specialties in Taiwan between 2000 and 2010. Clin. Ther. 37, 2275\u20132285 (2015).","journal-title":"Clin. Ther."},{"key":"35878_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.clinthera.2009.08.023","volume":"31","author":"HY Lai","year":"2009","unstructured":"Lai, H. Y. et al. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National health insurance program. Clin. Ther. 31, 1859\u20131870 (2009).","journal-title":"Clin. Ther."},{"key":"35878_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13584-022-00545-6","volume":"11","author":"I Lurie","year":"2022","unstructured":"Lurie, I., Maree, S., Mendlovic, S. & Shefet, D. Psychiatrists\u2019 awareness of the cost of medication, rates of social disability pension, and their attitudes regarding knowledge of treatment costs. Isr. J. Health Policy Res. 11, 35 (2022).","journal-title":"Isr. J. Health Policy Res."},{"key":"35878_CR22","first-page":"Cd003030","volume":"9","author":"L Forsetlund","year":"2021","unstructured":"Forsetlund, L. et al. Continuing education meetings and workshops: effects on professional practice and healthcare outcomes. Cochrane Database Syst. Rev. 9, Cd003030 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"35878_CR23","doi-asserted-by":"publisher","first-page":"2161730","DOI":"10.1080\/28338073.2022.2161730","volume":"12","author":"B Jenkins","year":"2023","unstructured":"Jenkins, B. et al. Evaluating the impact of continuing medical education in the interdisciplinary team: A Novel, targeted approach. J. Cme. 12, 2161730 (2023).","journal-title":"J. Cme"},{"key":"35878_CR24","doi-asserted-by":"publisher","first-page":"1338206","DOI":"10.3389\/fmed.2024.1338206","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Significant improvement of physicians\u2019 knowledge and clinical practice: an opportune, effective, and convenient continuing medical education program on functional dyspepsia. Front. Med. (Lausanne). 11, 1338206 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"35878_CR25","unstructured":"Centers for Disease Control and Prevention. COVID-19 Treatment Clinical Care for Outpatients (2025). https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/outpatient-treatment.html?utm_source=chatgpt.com"},{"key":"35878_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2185\/jrm.2021-056","volume":"17","author":"A Hara","year":"2022","unstructured":"Hara, A. et al. Japanese anesthesiologists\u2019 knowledge of the cost of medicines and their attitudes toward cost containment: a cross-sectional survey. J. Rural Med. 17, 131\u2013136 (2022).","journal-title":"J. Rural Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35878-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35878-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35878-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:02:39Z","timestamp":1770764559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35878-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35878"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35878-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kosaku Komiya has received lecture fees from Shionogi, Pfizer, and MSD. Akihiko Hagiwara declares no conflicts of interest related to this study. Yuichiro Shindo has received lecture fees from Kyorin Pharmaceutical, AstraZeneca, Nippon Boehringer Ingelheim, Gilead Sciences, MSD, GlaxoSmithKline, Insmed, Asahi Kasei Pharma, and Pfizer. Kazufumi Takamatsu declares no conflicts of interest related to this study. Naoki Nishimura declares no conflicts of interest related to this study. Yukako Takechi declares no conflicts of interest related to this study. Eiki Ichihara has received lecture fees from AstraZeneca, Pfizer, MSD, Chugai Pharmaceutical, Janssen Pharmaceutical, Kyowa Kirin, Novartis, Takeda Pharmaceutical, Daiichi Sankyo, and Boehringer Ingelheim. He has also received research funding from Janssen Pharmaceutical and a scholarship donation from Nippon Kayaku. Takahiro Takazono has received lecture fees from Shionogi, MSD, Pfizer, and Gilead Sciences. Shinyu Izumi declares no conflicts of interest related to this study. Shimpei Gotoh holds shares in HiLung, Inc. He has received research funding from Kyorin Pharmaceutical and Sumitomo Chemical and lecture fees from Chugai Pharmaceutical. Seiichiro Sakao declares no conflicts of interest related to this study. Takehiro Izumo has received lecture fees from AstraZeneca, MSD, and Daiichi Sankyo. Kazuko Yamamoto has received research grants from Taisho Pharmaceutical and Kirin Holdings Company. She has also received lecture fees from Shionogi, MSD, and Pfizer. Kazuhiro Yatera has received lecture fees from MSD, Pfizer, Shionogi, and Meiji Seika Pharma. Hiroshi Kakeya has received lecture fees from MSD, Pfizer, Shionogi, and Gilead Sciences. Yoko Shibata has received lecture fees from MSD and Shionogi. Keisuke Tomii declares no conflicts of interest related to this study. Hironori Sagara has received lecture fees from GlaxoSmithKline, Kyorin Pharmaceutical, AstraZeneca, Gilead Sciences, Pfizer, and MSD. Yuka Sasaki declares no conflicts of interest related to this study. Toyohiro Hirai has received lecture fees from MSD and Pfizer. Akihito Yokoyama declares no conflicts of interest related to this study. Hiroshi Mukae has received research funding from Shionogi and Kyorin Pharmaceutical. He has also received scholarship donations from Taiho Pharmaceutical, Nippon Boehringer Ingelheim, Chugai Pharmaceutical, Fujifilm, and Asahi Kasei Pharma. Additionally, he has received lecture fees from Kyorin Pharmaceutical, AstraZeneca, Shionogi, Pfizer, MSD, Nippon Boehringer Ingelheim, Chugai Pharmaceutical, and Fujifilm. Takashi Ogura has received lecture fees from Kyorin Pharmaceutical, Shionogi, Gilead Sciences, Fujifilm, Nippon Boehringer Ingelheim, and Chugai Pharmaceutical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5705"}}